Navigation Links
Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
Date:12/14/2010

PITTSBURGH, Dec. 14, 2010 /PRNewswire/ -- BIOSAFE, Inc. has announced that it has registered with the USEPA two new water-based antimicrobial solutions and entered into a commercialization agreement with Kentucky-based Union Springs Pharmaceuticals to market products containing BIOSAFE's patented and exclusive antimicrobial polymer, HM4100.  The unique and effective antimicrobial technology safely protects surfaces from harmful and degrading effects of bacteria, mold, mildew and fungi.  HM4100 is approved for uses in a variety of substrates, including textiles, plastics, medical goods, construction and building products, and consumer products.  This agreement gives Pittsburgh-based BIOSAFE greater access to the national and international marketplace, beginning with its first large order from Union Springs on December 6, 2010.

Union Springs offers MyClyns® (antimicrobial germ spray) and will offer products containing HM4100 under the MyClyns Antimicrobial Surface Treatments banner.  HM4100 is a residual long-term antimicrobial that has proven its effectiveness against the proliferation of such bacteria as MRSA, VREF and Staph, along with mold, mildew and some influenza A viruses that include bird flu (H5N1) and swine flue (H1N1).

Part of the significance of the BIOSAFE solution is that it can be applied to both hard and porous surfaces, from tables, desks and counters, to bedding, clothing and carpeting.

"This agreement with Union Springs Pharmaceuticals and the launch of MyClyns products featuring our patented HM4100 antimicrobial is more than just a business venture," said Max Fedor, CEO of BIOSAFE.  "The health protection benefits for millions of people around the world are potentially very significant.  Thanks to this strategic alliance with Union Springs Pharmaceuticals, we will be able to build a strong market presence around our unique technology."

Union Springs Pharmaceuticals plans to
'/>"/>

SOURCE BIOSAFE, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
(Date:10/20/2014)... , October 20, 2014 ... gastrointestinal (GI) disorders and the delivery of care has ... diseases and worrying inequalities in the provision of healthcare ... which was commissioned by United European Gastroenterology (UEG), have ... political and public awareness of the burden of GI ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is seeking ... stem cells for dogs with osteoarthritis. Dr. McCarthy has ... clinical stem cell therapy for 7 years. The ultimate ... single injection of donor stem cells into one or ... inflammation in the treated joints. , Candidates for ...
(Date:10/19/2014)... 19, 2014 The Asian Automatic patient ... with analysis and forecast of revenue. The Automatic patient ... around $463.9 million by 2018, at a developing CAGR ... the TOC of the Asian Automatic patient billing market, ... This also provides a glimpse of the segmentation of ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3
... Wis., Jan. 22 Mach One Corporation,(Pink Sheets: MNCN), ... positive long term benefit to the agricultural and consumer,market, ... Swap of,$1.5 million with an Investor. , ... facilitate the equipment purchase for,its first production facility in ...
... 22 Axikin Pharmaceuticals, Inc., a startup company ... for respiratory and inflammatory diseases, today announced a ... stock. The financing was led by Sanderling ... include Mitsui & Co. Venture Partners of New ...
... Calif., Jan. 22 Abaxis, Inc. (Nasdaq: ABAX ... has scheduled a conference call to discuss its financial results ... 31, 2008. The call will be at 4:15 p.m. ET ... (706) 643-0580 to access the conference call, or can listen ...
Cached Biology Technology:Mach One Completes Note Exchange 2Axikin Pharmaceuticals Spins out of Actimis 2Axikin Pharmaceuticals Spins out of Actimis 3Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009 2
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to ... the development of skin cancers by turning on an ... skin cells. , Previously considered protective, SIRT6 is part ... help regulate genomic stability and prevent some of the ... damage, which can lead to cancer. This study, in ...
(Date:10/14/2014)... to produce enough food to feed the world in ... of the United Nations predicts that food production must ... a growing global population, and plants are one major ... Plants—grains, cereals, fruits, vegetables, and more—feed humans directly and ... into our knowledge of how plants work to develop ...
(Date:10/14/2014)... Scientists from The Scripps Research Institute (TSRI) have been ... (NIH) to lead an investigation of Lassa fever virus, ... The study aims to understand how Lassa fever virus ... survive the inflection. , "The ultimate goal is ... Lassa fever virus causes disease and develop new treatments ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
... of Standards and Technology (NIST), in support of the ... validated the measurement accuracy of new techniques that use ... of cancer. Additional results suggest that a relatively simple ... early detection of some solid tumors, including lung cancer. ...
... the human antibody response to yellow fever, Howard Hughes ... the crucial bit of virus that people's immune systems ... , The findings may help scientists improve the existing ... Jan ter Meulen, an HHMI international research scholar and ...
... establishment of first polarity in the developing mammalian embryo ... biology today. Drs. Davor Solter and Takashi Hiiragi have ... techniques, including comprehensive time-lapse microscopy, the researchers showed compelling ... mouse egg. , Their findings are in contrast to ...
Cached Biology News:Fragment of yellow fever virus may hold key to safer vaccine 2Fragment of yellow fever virus may hold key to safer vaccine 3
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Request Info...
... Mung Bean Nuclease catalyzes the degradation ... yield 5-phosphoryl terminated products. While the nuclease ... very high concentrations the enzyme degrades double-stranded ... Nuclease has been used for transcript mapping ...
Biology Products: